A Double-blind, Placebo-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2014
At a glance
- Drugs Vilazodone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History